Senate Approps Bill Presses FDA To Implement OTC Sunscreen Rule
This article was originally published in The Rose Sheet
Executive Summary
An amendment to the Senate version of FDA's 2006 spending bill introduced by Chris Dodd (D-Conn.) urges the agency to publish UVA guidelines under the OTC sunscreen final monograph in the coming year
You may also be interested in...
Nanomaterial Sunscreens Should Be Designated “New Drugs” – Petition
FDA should amend the OTC final sunscreen monograph to specify that products containing engineered nanoparticles are excluded and designate the formulas "new drugs," a coalition of public interest groups states in a citizen petition
Nanomaterial Sunscreens Should Be Designated “New Drugs” – Petition
FDA should amend the OTC final sunscreen monograph to specify that products containing engineered nanoparticles are excluded and designate the formulas "new drugs," a coalition of public interest groups states in a citizen petition
EC Sheds Light On Recommended Sunscreen Labeling Options
Sunscreen protection levels would be ranked in four categories - low, medium, high or very high - on product labeling under a proposal by the European Commission